Effects of curcumin in children with cystic fibrosis
Phase 2
- Conditions
- cystic fibrosis.Cystic fibrosis, unspecifiedJ40-J47
- Registration Number
- IRCT2016022826798N1
- Lead Sponsor
- liver and gastrointestinal diseases research center, Tabriz University of medical sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 40
Inclusion Criteria
inclusion criteria:children with cystic fibrosis (age 5-18 year)
exclusion criteria:history of diabetes;cirhosis;hypoalbuminemia; severe respiratory failure dependent to oxygen therapy;intolerance of curcumin supplementation
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Pulmonary infection. Timepoint: before and after intervention. Method of measurement: questionnaire.;Duration of hospitalization. Timepoint: before and after intervention. Method of measurement: questionnaire.;Oral or Iv antibiotics administration. Timepoint: before and after intervention. Method of measurement: questionnaire.
- Secondary Outcome Measures
Name Time Method Height. Timepoint: before and after intervention. Method of measurement: mounted tape.;Weight. Timepoint: before and after intervention. Method of measurement: Seca scale.;Quality of life. Timepoint: before and after intervention. Method of measurement: Pedsql4 questionnaire.;Body mass index. Timepoint: before and after intervention. Method of measurement: weight (kg)/height (m)2.;Gastrointestinal disease symptoms. Timepoint: before and after intervention. Method of measurement: questinnnaire.